These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 24886632)
1. Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease. Vogel KR; Arning E; Wasek BL; McPherson S; Bottiglieri T; Gibson KM Orphanet J Rare Dis; 2014 May; 9():73. PubMed ID: 24886632 [TBL] [Abstract][Full Text] [Related]
2. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241 [TBL] [Abstract][Full Text] [Related]
3. Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. Dodd PR; Williams SH; Gundlach AL; Harper PA; Healy PJ; Dennis JA; Johnston GA J Neurochem; 1992 Aug; 59(2):582-90. PubMed ID: 1352800 [TBL] [Abstract][Full Text] [Related]
4. Classical maple syrup urine disease and brain development: principles of management and formula design. Strauss KA; Wardley B; Robinson D; Hendrickson C; Rider NL; Puffenberger EG; Shellmer D; Moser AB; Morton DH Mol Genet Metab; 2010 Apr; 99(4):333-45. PubMed ID: 20061171 [TBL] [Abstract][Full Text] [Related]
5. Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings. Vogel KR; Arning E; Wasek BL; Bottiglieri T; Gibson KM Mol Genet Metab; 2013; 110 Suppl(0):S71-8. PubMed ID: 23999161 [TBL] [Abstract][Full Text] [Related]
6. A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies. Bridi R; Fontella FU; Pulrolnik V; Braun CA; Zorzi GK; Coelho D; Wajner M; Vargas CR; Dutra-Filho CS J Neurosci Methods; 2006 Sep; 155(2):224-30. PubMed ID: 16530844 [TBL] [Abstract][Full Text] [Related]
7. Case report: Aqueous and Vitreous amino-acid concentrations in a patient with maple syrup urine disease operated on rhegmatogenous retinal detachment. Kanakis MG; Michelakakis H; Petrou P; Koutsandrea C; Georgalas I BMC Ophthalmol; 2016 Oct; 16(1):170. PubMed ID: 27716111 [TBL] [Abstract][Full Text] [Related]
8. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids. Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Ribeiro CA; Sgaravatti AM; Rosa RB; Schuck PF; Grando V; Schmidt AL; Ferreira GC; Perry ML; Dutra-Filho CS; Wajner M Neurochem Res; 2008 Jan; 33(1):114-24. PubMed ID: 17680360 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria. Parsons HG; Carter RJ; Unrath M; Snyder FF J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544 [TBL] [Abstract][Full Text] [Related]
11. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts. Skaper SD; Molden DP; Seegmiller JE Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377 [TBL] [Abstract][Full Text] [Related]
15. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro. Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137 [TBL] [Abstract][Full Text] [Related]
16. Tailoring of the diet for the individual in maple syrup urine disease: long-term home dietary treatment of an adult patient with MSUD by monitoring of daily intake with a personal computer. A case report. Lie IE; Haugstad S; Holm H Hum Nutr Appl Nutr; 1985 Apr; 39(2):130-6. PubMed ID: 3839494 [TBL] [Abstract][Full Text] [Related]
17. Maple syrup urine disease: Characteristics of diagnosis and treatment in 45 patients in Chile. Medina MF; Castro G; Falcon F; Cabello JF; Faundes V; Ruffato D; Salazar MF; Arias C; Peñaloza F; De La Parra A; Cornejo V Am J Med Genet C Semin Med Genet; 2021 Sep; 187(3):373-380. PubMed ID: 34288399 [TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid status in females of reproductive age with maple syrup urine disease. Mazer LM; Yi SH; Singh RH J Inherit Metab Dis; 2010 Apr; 33(2):121-7. PubMed ID: 20217236 [TBL] [Abstract][Full Text] [Related]